Anzeige
Mehr »
Samstag, 25.10.2025 - Börsentäglich über 12.000 News
Gold über 4.000 US-Dollar - Canary Gold startet Multi-Front-Exploration in Brasiliens neuem Gold-Hotspot
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PKZC | ISIN: US0887861088 | Ticker-Symbol: 50BA
Tradegate
24.10.25 | 09:30
6,600 Euro
-2,22 % -0,150
1-Jahres-Chart
BICYCLE THERAPEUTICS PLC ADR Chart 1 Jahr
5-Tage-Chart
BICYCLE THERAPEUTICS PLC ADR 5-Tage-Chart
RealtimeGeldBriefZeit
6,7006,90024.10.
6,6506,90024.10.

Aktuelle News zur BICYCLE THERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
08.09.Bicycle Therapeutics plc: Bicycle Therapeutics Strengthens Board of Directors with New Appointments420Roger Dansey, M.D., formerly Pfizer and Seagen, and Hervé Hoppenot, of Incyte and formerly Novartis Oncology, bring extensive drug development and commercialization expertise Bicycle Therapeutics...
► Artikel lesen
08.09.BICYCLE THERAPEUTICS PLC - 8-K, Current Report2
12.08.4 Analysts Assess Bicycle Therapeutics: What You Need To Know13
12.08.Bicycle Therapeutics stock price target lowered to $10 at Citizens JMP19
08.08.BICYCLE THERAPEUTICS PLC - 10-Q, Quarterly Report9
08.08.BICYCLE THERAPEUTICS PLC - 8-K, Current Report4
08.08.Bicycle Therapeutics plc: Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2025 Financial Results437Continued advancement across research and development pipeline, with key program updates expected in 2H 2025 Phase 1/2 Duravelo-4 trial for zelenectide pevedotin in NECTIN4-amplified non-small...
► Artikel lesen
BICYCLE THERAPEUTICS Aktie jetzt für 0€ handeln
18.07.Demystifying Bicycle Therapeutics: Insights From 7 Analyst Reviews17
02.07.Bicycle Therapeutics plc: Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)395Bicycle Therapeutics plc (NASDAQ: BCYC), today announced that on July 1, 2025, the Compensation Committee of the company's Board of Directors granted to eight new employees inducement awards consisting...
► Artikel lesen
17.06.BICYCLE THERAPEUTICS PLC - 8-K, Current Report13
03.06.Bicycle Therapeutics plc: Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)377Bicycle Therapeutics plc (NASDAQ: BCYC), today announced that on June 2, 2025, the Compensation Committee of the company's Board of Directors granted to seven new employees inducement awards consisting...
► Artikel lesen
22.05.Bicycle Therapeutics Announces Poster Presentations at the 2025 ASCO Annual Meeting543Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle) technology, today...
► Artikel lesen
05.05.Bicycle Therapeutics plc: Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)426Bicycle Therapeutics plc (NASDAQ: BCYC), today announced that on May 1, 2025, the Compensation Committee of the company's Board of Directors granted to 13 new employees inducement awards consisting...
► Artikel lesen
05.05.Morgan Stanley raises Bicycle Therapeutics target to $1722
02.05.Bicycle Therapeutics stock price target cut to $22 at Citizens JMP5
01.05.Bicycle Therapeutics reports Q1 results15
01.05.BICYCLE THERAPEUTICS PLC - 10-Q, Quarterly Report1
29.04.BICYCLE THERAPEUTICS PLC - 8-K, Current Report2
29.04.Bicycle Therapeutics plc: Bicycle Therapeutics Announces Presentation of Additional Human Radiopharmaceutical Imaging Data for MT1-MMP at the American Association for Cancer Research Annual Meeting 2025374Data continue to validate the potential of MT1-MMP as a novel cancer target and further underscore the applicability of Bicycle Radioconjugates (BRC) for radiopharmaceutical imaging Data are...
► Artikel lesen
02.04.Bicycle Therapeutics plc: Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)338Bicycle Therapeutics plc (NASDAQ: BCYC), today announced that on April 1, 2025, the Compensation Committee of the company's Board of Directors granted to eight new employees inducement awards consisting...
► Artikel lesen
Weiter >>
36 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1